

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.16932369 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.56531177 |
| 3 | muscle filament sliding (GO:0030049) | 8.56531177 |
| 4 | cardiac myofibril assembly (GO:0055003) | 8.37411214 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.98823610 |
| 6 | myofibril assembly (GO:0030239) | 7.89762970 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.16378302 |
| 8 | actin-mediated cell contraction (GO:0070252) | 7.12415527 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.08939758 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 7.08068760 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.87729371 |
| 12 | cardiac muscle contraction (GO:0060048) | 6.66459514 |
| 13 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.58618218 |
| 14 | plasma membrane repair (GO:0001778) | 6.39470639 |
| 15 | regulation of relaxation of muscle (GO:1901077) | 6.27184803 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.26215497 |
| 17 | cardiac muscle cell development (GO:0055013) | 6.24694645 |
| 18 | tricarboxylic acid cycle (GO:0006099) | 6.03191800 |
| 19 | actomyosin structure organization (GO:0031032) | 5.93483141 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.87856643 |
| 21 | cardiac cell development (GO:0055006) | 5.87237398 |
| 22 | striated muscle contraction (GO:0006941) | 5.80598724 |
| 23 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.78755305 |
| 24 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.58883978 |
| 25 | cardiac muscle hypertrophy (GO:0003300) | 5.56494078 |
| 26 | carnitine shuttle (GO:0006853) | 5.50460697 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.48565508 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 5.40054141 |
| 29 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.39071543 |
| 30 | adult heart development (GO:0007512) | 5.37877779 |
| 31 | actin filament-based movement (GO:0030048) | 5.36829396 |
| 32 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.35043451 |
| 33 | striated muscle hypertrophy (GO:0014897) | 5.33726734 |
| 34 | regulation of sarcomere organization (GO:0060297) | 5.31724356 |
| 35 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.28960140 |
| 36 | muscle tissue morphogenesis (GO:0060415) | 5.10642889 |
| 37 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.08069411 |
| 38 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.07392798 |
| 39 | regulation of striated muscle contraction (GO:0006942) | 4.99553857 |
| 40 | heart process (GO:0003015) | 4.89702877 |
| 41 | heart contraction (GO:0060047) | 4.89702877 |
| 42 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.89507433 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 4.76144467 |
| 44 | skeletal muscle contraction (GO:0003009) | 4.74170414 |
| 45 | heart trabecula formation (GO:0060347) | 4.72860539 |
| 46 | muscle hypertrophy (GO:0014896) | 4.72372335 |
| 47 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.68817602 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.59808005 |
| 49 | regulation of membrane repolarization (GO:0060306) | 4.53093488 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 4.46762333 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 4.46762333 |
| 52 | cell communication involved in cardiac conduction (GO:0086065) | 4.41487985 |
| 53 | regulation of the force of heart contraction (GO:0002026) | 4.39475411 |
| 54 | creatine metabolic process (GO:0006600) | 4.07050868 |
| 55 | carnitine transmembrane transport (GO:1902603) | 4.05238783 |
| 56 | * muscle contraction (GO:0006936) | 3.95795180 |
| 57 | regulation of cardiac muscle contraction (GO:0055117) | 3.94828500 |
| 58 | cell communication by electrical coupling (GO:0010644) | 3.93467174 |
| 59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.92595360 |
| 60 | cardiac muscle adaptation (GO:0014887) | 3.91881186 |
| 61 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.91881186 |
| 62 | muscle hypertrophy in response to stress (GO:0003299) | 3.91881186 |
| 63 | striated muscle cell development (GO:0055002) | 3.89885050 |
| 64 | cardiac muscle cell action potential (GO:0086001) | 3.87878760 |
| 65 | skeletal muscle adaptation (GO:0043501) | 3.87535464 |
| 66 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.84950414 |
| 67 | negative regulation of potassium ion transport (GO:0043267) | 3.82581293 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.79508058 |
| 69 | skeletal muscle fiber development (GO:0048741) | 3.79154941 |
| 70 | regulation of heart rate (GO:0002027) | 3.78676542 |
| 71 | cardiac chamber formation (GO:0003207) | 3.78438034 |
| 72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.78260322 |
| 73 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.77134141 |
| 74 | myotube cell development (GO:0014904) | 3.77126361 |
| 75 | response to inactivity (GO:0014854) | 3.76460080 |
| 76 | striated muscle adaptation (GO:0014888) | 3.75537119 |
| 77 | negative regulation of protein localization to cell surface (GO:2000009) | 3.75145888 |
| 78 | relaxation of cardiac muscle (GO:0055119) | 3.74907950 |
| 79 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.71204705 |
| 80 | * muscle system process (GO:0003012) | 3.69264325 |
| 81 | regulation of ATP catabolic process (GO:1903289) | 3.69217069 |
| 82 | regulation of ATPase activity (GO:0043462) | 3.69217069 |
| 83 | carnitine transport (GO:0015879) | 3.68325647 |
| 84 | amino-acid betaine transport (GO:0015838) | 3.68325647 |
| 85 | regulation of sulfur metabolic process (GO:0042762) | 3.64347309 |
| 86 | regulation of muscle system process (GO:0090257) | 3.62075888 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.59691420 |
| 88 | response to caffeine (GO:0031000) | 3.58720177 |
| 89 | skeletal muscle tissue development (GO:0007519) | 3.55409159 |
| 90 | relaxation of muscle (GO:0090075) | 3.54324950 |
| 91 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53579350 |
| 92 | regulation of cardioblast differentiation (GO:0051890) | 3.53121192 |
| 93 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.52947051 |
| 94 | oxidative phosphorylation (GO:0006119) | 3.52029283 |
| 95 | NADH metabolic process (GO:0006734) | 3.51854554 |
| 96 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.50859082 |
| 97 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.50859082 |
| 98 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.50784323 |
| 99 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.50784323 |
| 100 | ATP synthesis coupled proton transport (GO:0015986) | 3.48294103 |
| 101 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.48294103 |
| 102 | response to epinephrine (GO:0071871) | 3.46775868 |
| 103 | muscle cell cellular homeostasis (GO:0046716) | 3.46627938 |
| 104 | muscle adaptation (GO:0043500) | 3.45858880 |
| 105 | cardiac ventricle formation (GO:0003211) | 3.45679186 |
| 106 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.44566628 |
| 107 | regulation of heart contraction (GO:0008016) | 3.44538429 |
| 108 | regulation of muscle contraction (GO:0006937) | 3.44239511 |
| 109 | glycogen catabolic process (GO:0005980) | 3.42717361 |
| 110 | respiratory electron transport chain (GO:0022904) | 3.41234463 |
| 111 | positive regulation of cation channel activity (GO:2001259) | 3.39760861 |
| 112 | striated muscle atrophy (GO:0014891) | 3.37066266 |
| 113 | muscle fiber development (GO:0048747) | 3.35830476 |
| 114 | cardiac conduction (GO:0061337) | 3.35573175 |
| 115 | cellular response to epinephrine stimulus (GO:0071872) | 3.35537386 |
| 116 | muscle cell development (GO:0055001) | 3.34347405 |
| 117 | electron transport chain (GO:0022900) | 3.30797330 |
| 118 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25997560 |
| 119 | response to muscle activity (GO:0014850) | 3.24078323 |
| 120 | muscle cell fate commitment (GO:0042693) | 3.22787658 |
| 121 | glycogen biosynthetic process (GO:0005978) | 3.22555432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.34947814 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.09233101 |
| 3 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.22413229 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.22413229 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.09916724 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.85093685 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.46820493 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.43505623 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.39283030 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.37414896 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.82932837 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.74286656 |
| 13 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.50307585 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46769854 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.42771907 |
| 16 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.21287853 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.19018129 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96242106 |
| 19 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.91761365 |
| 20 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86415972 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83856826 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.78950538 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78657325 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.75253660 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72538213 |
| 26 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.72314277 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72013912 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60296048 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.50767064 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47202119 |
| 31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43253579 |
| 32 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.42669577 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42486266 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41507261 |
| 35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39338483 |
| 36 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39015292 |
| 37 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.38166564 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30023740 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27429273 |
| 40 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24296719 |
| 41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24164394 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22993418 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22120014 |
| 44 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21660186 |
| 45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21038899 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20875169 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18034458 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17435583 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17427768 |
| 50 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17225151 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15917104 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14847705 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14573631 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13724268 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12841365 |
| 56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10004274 |
| 57 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09922594 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08423547 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07817165 |
| 60 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07529205 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07528913 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07478458 |
| 63 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07159927 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05236605 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04969693 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04921271 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04697323 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04182598 |
| 69 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03872888 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03700432 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03247516 |
| 72 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02624894 |
| 73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02306312 |
| 74 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00471814 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00306089 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98467104 |
| 77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98381101 |
| 78 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98343580 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97989194 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97972927 |
| 81 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97701549 |
| 82 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97512031 |
| 83 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97512031 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97256524 |
| 85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95787948 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94753915 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93746072 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92569627 |
| 89 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92371105 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91779020 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90678002 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90336035 |
| 93 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90242920 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88427121 |
| 95 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.87895810 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87661315 |
| 97 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87173396 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86902337 |
| 99 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86305186 |
| 100 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.86086976 |
| 101 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85296177 |
| 102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84821996 |
| 103 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84151342 |
| 104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83551041 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82406541 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82299943 |
| 107 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.81629790 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81334185 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81080549 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80832772 |
| 111 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.80415295 |
| 112 | TBL1_22424771_ChIP-Seq_293T_Human | 0.80371691 |
| 113 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79408146 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79251305 |
| 115 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.79080846 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79048986 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78909008 |
| 118 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78590506 |
| 119 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.78495551 |
| 120 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77772355 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77673806 |
| 122 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.77100572 |
| 123 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.76699090 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76314783 |
| 125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.76274677 |
| 126 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.75771455 |
| 127 | P68_20966046_ChIP-Seq_HELA_Human | 0.75491022 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75339751 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75339751 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.75323663 |
| 131 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.75222386 |
| 132 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.74746474 |
| 133 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.74354646 |
| 134 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74314156 |
| 135 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.73982293 |
| 136 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73904715 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73754442 |
| 138 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73690444 |
| 139 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.73643770 |
| 140 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73212003 |
| 141 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.73141334 |
| 142 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.73112011 |
| 143 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.73059630 |
| 144 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.72460936 |
| 145 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.71979768 |
| 146 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.71553529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.34763367 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.52765752 |
| 3 | MP0003646_muscle_fatigue | 5.50665173 |
| 4 | MP0000751_myopathy | 5.31120557 |
| 5 | MP0000749_muscle_degeneration | 4.48908869 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.48458638 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.45406022 |
| 8 | MP0005330_cardiomyopathy | 3.81394373 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.39143380 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.30062812 |
| 11 | MP0002972_abnormal_cardiac_muscle | 3.04769166 |
| 12 | MP0005620_abnormal_muscle_contractility | 2.94921354 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.92518175 |
| 14 | MP0002106_abnormal_muscle_physiology | 2.92376421 |
| 15 | MP0008775_abnormal_heart_ventricle | 2.82830872 |
| 16 | MP0004130_abnormal_muscle_cell | 2.68349505 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.67340891 |
| 18 | MP0010630_abnormal_cardiac_muscle | 2.57134898 |
| 19 | MP0002269_muscular_atrophy | 2.55689680 |
| 20 | MP0000747_muscle_weakness | 2.46695968 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.46457232 |
| 22 | MP0001544_abnormal_cardiovascular_syste | 2.46457232 |
| 23 | MP0004484_altered_response_of | 2.42361821 |
| 24 | MP0005369_muscle_phenotype | 2.37680380 |
| 25 | MP0000759_abnormal_skeletal_muscle | 2.30911017 |
| 26 | MP0006138_congestive_heart_failure | 2.18913479 |
| 27 | MP0003828_pulmonary_edema | 2.10357502 |
| 28 | MP0004510_myositis | 2.03325965 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.95207284 |
| 30 | MP0004085_abnormal_heartbeat | 1.94353505 |
| 31 | MP0004233_abnormal_muscle_weight | 1.87694508 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.69980336 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.68250750 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.66318049 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.50883574 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.35941248 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.32883547 |
| 38 | MP0001661_extended_life_span | 1.21287751 |
| 39 | MP0000266_abnormal_heart_morphology | 1.13123955 |
| 40 | MP0005670_abnormal_white_adipose | 1.10722750 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.09469517 |
| 42 | MP0000343_altered_response_to | 1.07881589 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.04699745 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.03100584 |
| 45 | MP0000733_abnormal_muscle_development | 1.02026034 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.01763545 |
| 47 | MP0003279_aneurysm | 0.99884878 |
| 48 | MP0006035_abnormal_mitochondrial_morpho | 0.98572505 |
| 49 | MP0005165_increased_susceptibility_to | 0.95328908 |
| 50 | MP0005375_adipose_tissue_phenotype | 0.93710261 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 0.82090005 |
| 52 | MP0004270_analgesia | 0.79676149 |
| 53 | MP0003566_abnormal_cell_adhesion | 0.79640000 |
| 54 | MP0005266_abnormal_metabolism | 0.79252650 |
| 55 | MP0002128_abnormal_blood_circulation | 0.78282721 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.72963676 |
| 57 | MP0005275_abnormal_skin_tensile | 0.71718837 |
| 58 | MP0005623_abnormal_meninges_morphology | 0.70881191 |
| 59 | MP0000013_abnormal_adipose_tissue | 0.67008050 |
| 60 | MP0005451_abnormal_body_composition | 0.66938681 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 0.64399643 |
| 62 | MP0004272_abnormal_basement_membrane | 0.64220223 |
| 63 | MP0002971_abnormal_brown_adipose | 0.63566115 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.63090265 |
| 65 | MP0000767_abnormal_smooth_muscle | 0.60575621 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.57847991 |
| 67 | MP0000003_abnormal_adipose_tissue | 0.56654573 |
| 68 | MP0004043_abnormal_pH_regulation | 0.50161027 |
| 69 | MP0002925_abnormal_cardiovascular_devel | 0.48022434 |
| 70 | MP0002822_catalepsy | 0.47933516 |
| 71 | MP0009384_cardiac_valve_regurgitation | 0.47046077 |
| 72 | MP0004147_increased_porphyrin_level | 0.46287843 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.43094985 |
| 74 | MP0005187_abnormal_penis_morphology | 0.42473288 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.41518328 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.40951581 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.40392618 |
| 78 | MP0001784_abnormal_fluid_regulation | 0.38596066 |
| 79 | MP0003045_fibrosis | 0.38333934 |
| 80 | MP0001614_abnormal_blood_vessel | 0.37890602 |
| 81 | MP0003984_embryonic_growth_retardation | 0.37294383 |
| 82 | MP0002088_abnormal_embryonic_growth/wei | 0.36735876 |
| 83 | MP0008569_lethality_at_weaning | 0.35182268 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.35078761 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.32190507 |
| 86 | MP0000372_irregular_coat_pigmentation | 0.30125965 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.30065894 |
| 88 | MP0005334_abnormal_fat_pad | 0.28244073 |
| 89 | MP0003879_abnormal_hair_cell | 0.25501883 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.24928807 |
| 91 | MP0005503_abnormal_tendon_morphology | 0.24369808 |
| 92 | MP0001958_emphysema | 0.23280768 |
| 93 | MP0004134_abnormal_chest_morphology | 0.23232812 |
| 94 | MP0005535_abnormal_body_temperature | 0.23106625 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.22694086 |
| 96 | MP0001984_abnormal_olfaction | 0.22394126 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.21571896 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.21517535 |
| 99 | MP0003941_abnormal_skin_development | 0.20654313 |
| 100 | MP0009115_abnormal_fat_cell | 0.20480417 |
| 101 | MP0008004_abnormal_stomach_pH | 0.20303557 |
| 102 | MP0000762_abnormal_tongue_morphology | 0.19189770 |
| 103 | MP0001727_abnormal_embryo_implantation | 0.18742917 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.18696577 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.18187857 |
| 106 | MP0000579_abnormal_nail_morphology | 0.18148458 |
| 107 | MP0000249_abnormal_blood_vessel | 0.17900853 |
| 108 | MP0005452_abnormal_adipose_tissue | 0.17632510 |
| 109 | MP0004924_abnormal_behavior | 0.17427429 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.17427429 |
| 111 | MP0006276_abnormal_autonomic_nervous | 0.17272780 |
| 112 | MP0008874_decreased_physiological_sensi | 0.17003950 |
| 113 | MP0004142_abnormal_muscle_tone | 0.16473545 |
| 114 | MP0005332_abnormal_amino_acid | 0.16273036 |
| 115 | MP0002118_abnormal_lipid_homeostasis | 0.16237504 |
| 116 | MP0002133_abnormal_respiratory_system | 0.16141365 |
| 117 | MP0005388_respiratory_system_phenotype | 0.16141365 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.15902289 |
| 119 | MP0005380_embryogenesis_phenotype | 0.15902289 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.15721781 |
| 121 | MP0009672_abnormal_birth_weight | 0.15386237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.83888595 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.75285451 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.69493388 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.67192675 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.41243798 |
| 6 | Ventricular tachycardia (HP:0004756) | 6.29337011 |
| 7 | Muscle fiber splitting (HP:0003555) | 6.05168711 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.50993484 |
| 9 | Atrial fibrillation (HP:0005110) | 5.36223890 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.31384155 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.20094797 |
| 12 | Subaortic stenosis (HP:0001682) | 5.20094797 |
| 13 | Myoglobinuria (HP:0002913) | 5.12316455 |
| 14 | Primary atrial arrhythmia (HP:0001692) | 5.00627400 |
| 15 | Lipoatrophy (HP:0100578) | 4.94549798 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.83532398 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 4.75016972 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 4.74348875 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 4.70989826 |
| 20 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.68187366 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.64471067 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 4.44546948 |
| 23 | Syncope (HP:0001279) | 4.33780364 |
| 24 | Increased connective tissue (HP:0009025) | 4.27829038 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 4.16582040 |
| 26 | Difficulty running (HP:0009046) | 4.09780140 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 4.05504876 |
| 28 | Rhabdomyolysis (HP:0003201) | 4.04334825 |
| 29 | Nemaline bodies (HP:0003798) | 4.01018395 |
| 30 | Bundle branch block (HP:0011710) | 3.99603544 |
| 31 | Prolonged QT interval (HP:0001657) | 3.88620506 |
| 32 | Palpitations (HP:0001962) | 3.87288717 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.77668626 |
| 34 | Myotonia (HP:0002486) | 3.67266417 |
| 35 | Calcaneovalgus deformity (HP:0001848) | 3.45481111 |
| 36 | Heart block (HP:0012722) | 3.38713942 |
| 37 | Atrioventricular block (HP:0001678) | 3.22530017 |
| 38 | Abnormal atrioventricular conduction (HP:0005150) | 3.20224529 |
| 39 | Difficulty climbing stairs (HP:0003551) | 3.17041402 |
| 40 | Ventricular fibrillation (HP:0001663) | 3.16862540 |
| 41 | Absent phalangeal crease (HP:0006109) | 3.15154986 |
| 42 | Muscle stiffness (HP:0003552) | 3.09487231 |
| 43 | Neck muscle weakness (HP:0000467) | 3.04275094 |
| 44 | Deformed tarsal bones (HP:0008119) | 3.03660397 |
| 45 | Distal arthrogryposis (HP:0005684) | 3.03189984 |
| 46 | Increased variability in muscle fiber diameter (HP:0003557) | 2.91990130 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.88558620 |
| 48 | Abnormal EKG (HP:0003115) | 2.78396836 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.71818401 |
| 50 | Rimmed vacuoles (HP:0003805) | 2.70580991 |
| 51 | Round ear (HP:0100830) | 2.70042849 |
| 52 | Malignant hyperthermia (HP:0002047) | 2.66401164 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.64140907 |
| 54 | Left ventricular hypertrophy (HP:0001712) | 2.63245037 |
| 55 | Abnormal finger flexion creases (HP:0006143) | 2.59043858 |
| 56 | Myopathic facies (HP:0002058) | 2.58067889 |
| 57 | Hip contracture (HP:0003273) | 2.53729319 |
| 58 | Palmoplantar keratoderma (HP:0000982) | 2.45492087 |
| 59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.41423135 |
| 60 | Bulbar palsy (HP:0001283) | 2.38933707 |
| 61 | Hepatic necrosis (HP:0002605) | 2.37424918 |
| 62 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.36271681 |
| 63 | Hypoplastic ischia (HP:0003175) | 2.34862756 |
| 64 | Fetal akinesia sequence (HP:0001989) | 2.33841552 |
| 65 | EMG: neuropathic changes (HP:0003445) | 2.33642140 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.29777893 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.28533897 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.28443252 |
| 69 | Ketoacidosis (HP:0001993) | 2.28336045 |
| 70 | Generalized muscle weakness (HP:0003324) | 2.28074520 |
| 71 | Muscular dystrophy (HP:0003560) | 2.21503760 |
| 72 | Hypoglycemic coma (HP:0001325) | 2.19927954 |
| 73 | Scapular winging (HP:0003691) | 2.15918438 |
| 74 | Facial diplegia (HP:0001349) | 2.14535486 |
| 75 | Ulnar deviation of the wrist (HP:0003049) | 2.13910247 |
| 76 | Conjunctival hamartoma (HP:0100780) | 2.13390488 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.11866072 |
| 78 | Weak cry (HP:0001612) | 2.11533562 |
| 79 | Gowers sign (HP:0003391) | 2.10086239 |
| 80 | Abnormality of the foot musculature (HP:0001436) | 2.06979387 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.06769352 |
| 82 | Abnormality of the ischium (HP:0003174) | 2.04740577 |
| 83 | Hepatocellular necrosis (HP:0001404) | 2.01983296 |
| 84 | Testicular atrophy (HP:0000029) | 1.99448452 |
| 85 | Abnormality of the neuromuscular junction (HP:0003398) | 1.99397849 |
| 86 | Fatigable weakness (HP:0003473) | 1.99397849 |
| 87 | Increased muscle lipid content (HP:0009058) | 1.99158706 |
| 88 | Frequent falls (HP:0002359) | 1.97417342 |
| 89 | Sudden cardiac death (HP:0001645) | 1.96744149 |
| 90 | Acute encephalopathy (HP:0006846) | 1.93975923 |
| 91 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93575367 |
| 92 | Exercise intolerance (HP:0003546) | 1.93220525 |
| 93 | Abnormality of the calcaneus (HP:0008364) | 1.93158784 |
| 94 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.93115472 |
| 95 | Foot dorsiflexor weakness (HP:0009027) | 1.92543615 |
| 96 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91703310 |
| 97 | Waddling gait (HP:0002515) | 1.90742492 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89359488 |
| 99 | Dicarboxylic aciduria (HP:0003215) | 1.89359488 |
| 100 | Progressive macrocephaly (HP:0004481) | 1.89198874 |
| 101 | Congestive heart failure (HP:0001635) | 1.87774614 |
| 102 | Lower limb amyotrophy (HP:0007210) | 1.86463020 |
| 103 | Steppage gait (HP:0003376) | 1.86275113 |
| 104 | Mitochondrial inheritance (HP:0001427) | 1.84515758 |
| 105 | Proximal amyotrophy (HP:0007126) | 1.84453623 |
| 106 | Progressive muscle weakness (HP:0003323) | 1.82619079 |
| 107 | Cerebral edema (HP:0002181) | 1.79558510 |
| 108 | Increased CSF lactate (HP:0002490) | 1.79423549 |
| 109 | Hyperkalemia (HP:0002153) | 1.79009685 |
| 110 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.78567738 |
| 111 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.77984313 |
| 112 | Abnormality of alanine metabolism (HP:0010916) | 1.77984313 |
| 113 | Hyperalaninemia (HP:0003348) | 1.77984313 |
| 114 | Limited hip movement (HP:0008800) | 1.77909877 |
| 115 | Slender build (HP:0001533) | 1.75235859 |
| 116 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74957266 |
| 117 | Broad metatarsal (HP:0001783) | 1.74947932 |
| 118 | Spinal rigidity (HP:0003306) | 1.74105841 |
| 119 | Pheochromocytoma (HP:0002666) | 1.73227824 |
| 120 | Hamartoma of the eye (HP:0010568) | 1.73187726 |
| 121 | Metatarsus adductus (HP:0001840) | 1.70349187 |
| 122 | Popliteal pterygium (HP:0009756) | 1.63161526 |
| 123 | Hypoplastic heart (HP:0001961) | 1.54531208 |
| 124 | Aplasia of the musculature (HP:0100854) | 1.46359924 |
| 125 | Limb-girdle muscle weakness (HP:0003325) | 1.46030523 |
| 126 | Type 2 muscle fiber atrophy (HP:0003554) | 1.42200298 |
| 127 | Oligomenorrhea (HP:0000876) | 1.41381916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.65254136 |
| 2 | TTN | 5.84735338 |
| 3 | PHKG2 | 4.25028123 |
| 4 | PHKG1 | 4.25028123 |
| 5 | PDK4 | 3.21642245 |
| 6 | PDK3 | 3.21642245 |
| 7 | MYLK | 3.18014664 |
| 8 | DMPK | 3.16106879 |
| 9 | LMTK2 | 3.03982360 |
| 10 | PKN2 | 2.95767995 |
| 11 | TRIB3 | 2.54712835 |
| 12 | NEK1 | 2.36906139 |
| 13 | PIK3CA | 2.28445401 |
| 14 | MUSK | 2.13372539 |
| 15 | STK24 | 2.11211973 |
| 16 | BCKDK | 1.95922847 |
| 17 | PDK2 | 1.95522793 |
| 18 | TIE1 | 1.89789617 |
| 19 | PINK1 | 1.79291753 |
| 20 | ZAK | 1.39947306 |
| 21 | MAP3K7 | 1.36091362 |
| 22 | ILK | 1.26189199 |
| 23 | MAP2K3 | 1.24799046 |
| 24 | MARK1 | 1.22046062 |
| 25 | PIK3CG | 1.21695049 |
| 26 | GRK7 | 1.19262015 |
| 27 | MAPK12 | 1.13703955 |
| 28 | NME1 | 1.11764734 |
| 29 | CAMK2D | 1.09848475 |
| 30 | PRKD1 | 1.09476669 |
| 31 | PAK3 | 1.04005036 |
| 32 | TRPM7 | 0.97572762 |
| 33 | INSRR | 0.97133077 |
| 34 | ROCK1 | 0.93260956 |
| 35 | PRKAA2 | 0.90157750 |
| 36 | CDC42BPA | 0.89637912 |
| 37 | FLT3 | 0.89291175 |
| 38 | PRKAA1 | 0.88597040 |
| 39 | EEF2K | 0.87086837 |
| 40 | MAPKAPK3 | 0.86590465 |
| 41 | RIPK1 | 0.86149242 |
| 42 | WNK4 | 0.81731664 |
| 43 | STK38L | 0.81562621 |
| 44 | MAP3K5 | 0.76778894 |
| 45 | MAP3K3 | 0.75235664 |
| 46 | STK4 | 0.71912504 |
| 47 | CCNB1 | 0.67673722 |
| 48 | PDGFRA | 0.65010640 |
| 49 | PKN1 | 0.62770164 |
| 50 | EPHA3 | 0.62743695 |
| 51 | MAPK4 | 0.60726749 |
| 52 | DAPK3 | 0.59147081 |
| 53 | CAMK4 | 0.58214724 |
| 54 | MOS | 0.56999635 |
| 55 | NEK9 | 0.56742103 |
| 56 | WNK1 | 0.55880960 |
| 57 | TGFBR2 | 0.54088791 |
| 58 | ERBB3 | 0.52988155 |
| 59 | MAP3K6 | 0.50893188 |
| 60 | STK38 | 0.50211801 |
| 61 | KDR | 0.49356171 |
| 62 | EPHB1 | 0.49185887 |
| 63 | ROCK2 | 0.48584627 |
| 64 | DYRK1B | 0.48436902 |
| 65 | MAP2K1 | 0.47962568 |
| 66 | CAMK2B | 0.47765354 |
| 67 | PTK2B | 0.46932691 |
| 68 | CAMK2A | 0.46082476 |
| 69 | PRKACB | 0.46010893 |
| 70 | AKT2 | 0.45111063 |
| 71 | CAMK1 | 0.44170329 |
| 72 | SIK1 | 0.43311688 |
| 73 | KSR2 | 0.42793939 |
| 74 | PTK6 | 0.38632427 |
| 75 | LATS1 | 0.38144611 |
| 76 | RPS6KL1 | 0.37690858 |
| 77 | RPS6KC1 | 0.37690858 |
| 78 | CAMK2G | 0.37674125 |
| 79 | SGK2 | 0.34333636 |
| 80 | STK39 | 0.34032256 |
| 81 | MAP2K4 | 0.32237614 |
| 82 | * PRKACA | 0.32221557 |
| 83 | ICK | 0.31806480 |
| 84 | PDPK1 | 0.30659841 |
| 85 | RPS6KA6 | 0.30011801 |
| 86 | MAP2K6 | 0.27682876 |
| 87 | PDK1 | 0.27049952 |
| 88 | PRKCE | 0.26857674 |
| 89 | MAPK10 | 0.25275565 |
| 90 | PRKG1 | 0.24814317 |
| 91 | MAP3K10 | 0.24518795 |
| 92 | * PRKACG | 0.24009904 |
| 93 | MARK2 | 0.22601953 |
| 94 | NLK | 0.22362337 |
| 95 | MAPK11 | 0.21893888 |
| 96 | MTOR | 0.21399735 |
| 97 | RPS6KA1 | 0.20800308 |
| 98 | MAP3K13 | 0.20290476 |
| 99 | LIMK1 | 0.20159600 |
| 100 | PRKCH | 0.19328473 |
| 101 | RET | 0.19297465 |
| 102 | LATS2 | 0.18464434 |
| 103 | STK11 | 0.18424895 |
| 104 | FER | 0.18128897 |
| 105 | MAPK7 | 0.17499471 |
| 106 | EPHB2 | 0.17455277 |
| 107 | SGK1 | 0.16691688 |
| 108 | RPS6KB2 | 0.16476896 |
| 109 | JAK1 | 0.16287214 |
| 110 | LRRK2 | 0.16254016 |
| 111 | SGK3 | 0.15802444 |
| 112 | DDR2 | 0.15797142 |
| 113 | PRKG2 | 0.15682463 |
| 114 | RAF1 | 0.15587131 |
| 115 | RPS6KA3 | 0.15504694 |
| 116 | ZAP70 | 0.15353319 |
| 117 | SGK223 | 0.14484700 |
| 118 | SGK494 | 0.14484700 |
| 119 | FGFR3 | 0.13243674 |
| 120 | PRKD3 | 0.10402142 |
| 121 | TAOK1 | 0.09220535 |
| 122 | PDGFRB | 0.08706661 |
| 123 | RPS6KA2 | 0.07642798 |
| 124 | FGFR1 | 0.06610105 |
| 125 | MAP3K1 | 0.06300391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.80607656 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.39023733 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.16765965 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.14969389 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.11089587 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05187208 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01034272 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.95719162 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.80403444 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68947073 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.63518868 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.42123377 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.11236003 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06863281 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01443215 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95033876 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.90904496 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.84142779 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68541078 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67641373 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38884062 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32698137 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31817671 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.29635951 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.25040780 |
| 26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.18075551 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15069596 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13867746 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.11720694 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.10574969 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09697163 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97342192 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 0.94187500 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92093525 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91375135 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87261951 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87046904 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86818696 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86134506 |
| 40 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80016716 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 0.79020260 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77105542 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74045472 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 0.73487878 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64547631 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64199976 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63847750 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63418160 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63244703 |
| 50 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62983262 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62253991 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61683822 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61069276 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59307780 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58124843 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.53748161 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.53366515 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.51875539 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51120593 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50182594 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49927948 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49660955 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49267867 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47694994 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46008666 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42770183 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.41887306 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40935670 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.39790719 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37489972 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37444701 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33609787 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33262744 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.32972917 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32907179 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30610926 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30479088 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.28876821 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26593430 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26468168 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.25890288 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25713121 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.24415432 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23870333 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23241506 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.23216982 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20847753 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18928288 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18695140 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17847634 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17475310 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.16363531 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15706045 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15378756 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.15287198 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.15250837 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.13744639 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12689754 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.12409070 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11882579 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.11488529 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.10958458 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.10855681 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.10758208 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10537428 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08940733 |
| 107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.08369255 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.08143806 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07839921 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.07142289 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06834978 |
| 112 | Gap junction_Homo sapiens_hsa04540 | 0.06269666 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.04899447 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03943351 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.03614918 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.02806479 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0046329 |

